Clinical Trial Update: A Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis [Phase 1, Phase 2]

View source ↗

Summary

Genentech is conducting a Phase 1/2 clinical trial to evaluate the activity and safety of Vixarelimab in participants with moderate to severe ulcerative colitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Vixarelimab (vixarelimab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Moderate to Severe Ulcerative Colitis | Phase 1, Phase 2 | Status: RECRUITING